What’s The Plan? US FDA Drug Development Tool Qualification Process Requires “Cultural Change”
FDA sees negotiating formal “qualification plan” as key process improvement that should ultimately accelerate pace for construction of biomarkers and other drug development tools. But it will take some getting used to.
